尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Breedlove Robert Charles. Insider active across 1 company, notably Phathom Pharmaceuticals, Inc.. Cumulatively, 8 filings have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €23k. Activity tracked since 16 July 2025. The latest transaction was disclosed on 3 September 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Breedlove Robert Charles is a declarant connected to Phathom Pharmaceuticals, Inc. (XNAS), where the listed role is Principal Accounting Officer. He has 7 filings in total, and across the 7 sampled filings between 2025-07-18 and 2026-07-16, the sell amount is EUR 23084, with the dominant transaction nature listed as tax withholding.